Tag: Revolo Biotherapeutics

Revolo Therapeutics

Revolo Biotherapeutics Announces Open Enrollment for Phase 2 Clinical Trial of...

Revolo Biotherapeutics announced it has activated clinical sites and opened enrollment in a Phase 2 clinical trial of its eosinophilic esophagitis therapy.